검색어 : 통합검색[351.7]
총 2,653건 중 1,000건 출력
, 8/100 페이지
-
71
- Prada, Massimo (2022), Non solo parole: percorsi di didattica della scrittura. Dai testi funzionali a quelli multimodali, FrancoAngeli, 314 p. [ISBN: 978-88-351-0693-7]
- Rodolico Francesca; ; (Circula, v., 2022, pp.275-279)
-
72
- Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2
- O'Toole, Á ine; Hill, Verity; Pybus, Oliver G.; Watts, Alexander; Bogoch, Issac I.; Khan, Kamran; Messina, Jane P.; Tegally, Houriiyah; Lessells, Richard R.; Giandhari, Jennifer; Pillay, Sureshnee; Tumedi, Kefentse Arnold; Nyepetsi, Gape; Kebabonye, Malebogo; Matsheka, Maitshwarelo; Mine, Madisa; Tokajian, Sima; Hassan, Hamad; Salloum, Tamara; Merhi, Georgi; Koweyes, Jad; Geoghegan, Jemma L.; de Ligt, Joep; Ren, Xiaoyun; Storey, Matthew; Freed, Nikki E.; Pattabiraman, Chitra; Prasad, Pramada; Desai, Anita S.; Vasanthapuram, Ravi; Schulz, Thomas F.; Steinbrü ck, Lars; Stadler, Tanja; Parisi, Antonio; Bianco, Angelica; Garcí a de Viedma, Darí o; Buenestado-Serrano, Sergio; Borges, Ví tor; Isidro, Joana; Duarte, Sí lvia; Gomes, Joã o Paulo; Zuckerman, Neta S.; Mandelboim, Michal; Mor, Orna; Seemann, Torsten; Arnott, Alicia; Draper, Jenny; Gall, Mailie; Rawlinson, William; Deveson, Ira; Schlebusch, Sa; ; (Wellcome open research, v.6, 2021, pp.121)
-
73
- CPX-351 versus 7+3 dans la leucémie aiguë myéloïde du sujet âgé : avantage en survie globale conservée à cinq ans
- Saillant, Arnaud; Moya, Niels; Leleu, Xavier; ; (Hématologie, v.27, 2021, pp.215-217)
-
74
- Multiple partition Markov model for B.1.1.7, B.1.351, B.1.617.2, and P.1 variants of SARS-CoV 2 virus
- García Jesús Enrique; González-López Verónica Andrea; Tasca Gustavo Henrique; ; (Computational Statistics, v., 2022, )
-
75
- The glass-lubricated extrusion of steel - R. Cockroft, Metals Mater., 3 (9) (1969) 351-355; 7 figs., 2 tables, 4 refs.
- ; ; (Wear: An international journal on the science and technology of friction, lubrication and wear, v.14, 1969, pp.298)
-
76
- ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7
- Fischer, Robert J.; van Doremalen, Neeltje; Adney, Danielle R.; Yinda, Claude Kwe; Port, Julia R.; Holbrook, Myndi G.; Schulz, Jonathan E.; Williamson, Brandi N.; Thomas, Tina; Barbian, Kent; Anzick, Sarah L.; Ricklefs, Stacy; Smith, Brian J.; Long, Dan; Martens, Craig; Saturday, Greg; de Wit, Emmie; Gilbert, Sarah C.; Lambe, Teresa; Munster, Vincent J.; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT USA; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT USA; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT USA; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT USA; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT USA; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT USA; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT USA; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institute; (Nature communications, v.12, 2021, pp.5868)
-
77
- Extract from Cistus × Incanus L. Pandalis also Effective Against “British” Alpha (B.1.1.7) and “South African” Beta (B.1.351) SARS-CoV-2 Variants
- Traeder Jens-Martin; ; (Journal of Diseases and Medicinal Plants, v.7, 2021, pp.44-44)
-
78
- Abstract 351: Preclinical development of MHB009C: A novel anti-B7-H4 ADC with a potent topoisomerase I inhibitor
- Zhu, Liyuan; Liu, Bo; Chen, Yile; Meng, Xiang; Li, Ao; Liu, Li; Yao, Zhili; Wang, Yan; Weng, Xialian; Zhu, Xuefeng; Liu, Yang; Zhou, Shiyu; Shi, Junwei; Cao, Guoqing; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; Minghui Pharmaceutical, Hangzhou, China.; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.85, 2025, pp.351-351)
-
79
- Design of Specific Primer Sets for the Detection of B.1.1.7, B.1.351 and P.1 SARS-CoV-2 Variants using Deep Learning
- Lopez-Rincon Alejandro; Perez-Romero Carmina A.; Tonda Alberto; Mendoza-Maldonado Lucero; Claassen Eric; Garssen Johan; Kraneveld Aletta D.; ; (, v., 2021, )
-
80
- Complete Genome Sequence of Human Oral <i>Actinomyces</i> sp. HMT897 Strain ORNL0104, a Host of the Saccharibacterium (TM7) HMT351
- Cross, Karissa L.; Dewhirst, Floyd; Podar, Mircea; Gill, Steven R.; Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA; Department of Microbiology, The Forsyth Institute, Cambridge, Massachusetts, USA; Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA; (Microbiology resource announcements, v.10, 2021, pp.e00040-21-e00040-21)
QUICK MENU
